Johnson & Johnson to Acquire V-Wave for $600 Million
On August 20, Johnson & Johnson (J&J) announced that it entered into an agreement to acquire V-Wave Ltd. for an upfront price of $600 million. V-Wave is a privately held medical device company that was established in 2009 and is focused on developing innovative treatment options for people living with heart failure and cardiovascular disease. V-Wave’s cardiovascular implant technology specifically targets heart failure with reduced ejection fraction. The company is based in Pardes Hana – Karkur, Israel. J&J is one of the largest global healthcare and pharmaceutical companies with more than 130,000 employees worldwide. Its business lines include... Read More »
Hologic Completes Acquisition of Endomagnetics
Hologic, Inc. announced on July 25 that it completed its previously announced acquisition of Endomagnetics Ltd, a privately held UK-based developer of breast cancer surgery technologies, for approximately $310 million. Endomagnetics, also called Endomag, develops and sells breast surgery localization and lymphatic tracing technologies. The Cambridge, United Kingdom-based company was founded in 2007 and produces surgical guidance products that assist surgeons in locating and removing cancerous tumors, predominantly for breast cancer surgery. Its products include the Magseed® marker for magnetic tissue localization before surgery, the Magtrace® lymphatic tracing injectable for breast cancer... Read More »
Earnings Week in Review: Healthcare Giants Navigate Growth and Hurdles
We’re taking a look at some of the major companies reporting earnings in the week of July 15-July 19, across a variety of sectors. UnitedHealth Group and Novartis showcased strong growth, while Johnson & Johnson and Elevance Health presented more mixed results. Abbott Laboratories also reported solid results, driven by its medical devices segment, while facing challenges in its diagnostics business due to waning COVID-19 testing demand. This week’s earnings reports offer insights into the broader healthcare industry’s performance and future trajectory. UnitedHealth Group UnitedHealth Group (UHG) demonstrated a significant turnaround in its second quarter of 2024, posting a... Read More »
Edwards Lifesciences to Acquire Innovalve
Edwards Lifesciences announced on July 15 that it has exercised its option to acquire Innovalve Bio Medical Ltd. following its initial investment in 2017. The purchase price is about $300 million in cash. Innovalve Bio Medical Ltd. is an early-stage medical device company that develops catheter-based heart valve therapies. The company was founded in 2017 and is based in Israel. Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via... Read More »
PE-Backed Riverpoint Medical Acquires CP Medical
Riverpoint Medical announced that it has completed the acquisition of CP Medical. Riverpoint is a portfolio company of Arlington Capital Partners, a Washington, D.C.-area private investment firm specializing in government-regulated industries. CP Medical is a Norcross, Georgia-based manufacturer of surgical solutions, specializing in products for wound closure as well as for specialty surgical applications. CP Medical also manufactures a comprehensive portfolio of private-label sutures and wound closure products, sold through a global network of distributors, for the veterinary and human medical market. Headquartered in Portland, Oregon, Riverpoint Medical is a developer, designer and... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
